Brief: Insmed Reports Fourth-Quarter And Full-Year 2025 Financial Results And Provides Business Update
19/02/2026 12:56
Feb 19 (Reuters) - Insmed Inc INSM.O: INSMED REPORTS FOURTH-QUARTER AND FULL-YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE INSMED INC - EXPECTS 2026 BRINSUPRI REVENUES TO EXCEED $1 BILLION INSMED INC - REITERATES 2026 ARIKAYCE REVENUE GUIDANCE OF $450-$470 MILLION Source text: ID:nPn2CHWNwa Further company coverage: INSM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insmed Incorporated
See all newsBrief: Insmed Launches Brinsupri® Tablets 25 Mg (Brensocatib Hydrate) For The Treatment Of Non-Cystic Fibrosis Bronchiectasis In Japan
Brief: Insmed Incorporated - Launches Four Pivotal Phase 3 Studies For TPIP In Pulmonary Diseases
U.S. STOCKS ON THE MOVE-Nike, Synopsys, Intel
Insmed CFO Sara Bonstein steps down; shares fall
U.S. STOCKS ON THE MOVE- Cenovus Energy, TeraWulf, Alector